Search clinical trials for: anticoagulation treatment

Total 64046 results

Region Skane
The George Institute for Global Health, Australia

Not yet recruiting

International Care Bundle Evaluation in Cerebral Hemorrhage Research (I-CATCHER)

Stroke | Intraventricular Hemorrhage | Cerebrovascular Disease | Intracerebral Hemorrhage | Intracerebral Haemorrhage

Australia, Sweden
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Evaluation of Safety and Efficacy of Anticoagulation Treatment in Patients With Splanchnic Vein Thrombosis: SAPIENT Study (SAPIENT)

Splanchnic Vein Thrombosis

Italy
Penumbra Inc.

Recruiting

Comparison of Two Pulmonary Embolism Treatments

Pulmonary Embolism Acute

United States
McMaster University
International Society on Thrombosis and Haemostasis

Recruiting

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Antiphospholipid Syndrome | Arterial Thrombosis

Argentina, Canada
Ege University

Recruiting

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism

Pulmonary Embolism

Turkey
University of Zagreb

Recruiting

The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome

Burning Mouth Syndrome

Croatia
Centre Hospitalier Universitaire Dijon

Recruiting

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study (API-AHAI)

Autoimmune Hemolytic Anemia | Venous Thromboembolic Disease | Prolonged Anticoagulation

France
Qilu Hospital of Shandong University

Recruiting

Treatment and Clinical Outcomes Among SLE Patients in Pregnancy

Systemic Lupus Erythematosus | Pregnancy Related

China
University of Birmingham
Royal United Hospitals Bath NHS Foundation Trust; Cimar

Recruiting

STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism (STOPAPE)

Subsegmental Pulmonary Embolism Nos

United Kingdom
University Hospital, Grenoble

Recruiting

Angioplasty-stenting vs Optimal Medical Treatment on Post-thrombotic Syndrome Reduction (EndoPTS)

Post Thrombotic Syndrome

France
Population Health Research Institute
Hamilton Health Sciences Corporation

Recruiting

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery (ASPIRE-AF)

Stroke | Atrial Fibrillation

Canada, Australia, Germany, Denmark, Switzerland, Spain, Korea, Republic of, New Zealand, Argentina, India, Netherlands, United Kingdom, Brazil, Italy, Nepal, Sweden, Pakistan
Pirogov Russian National Research Medical University

Recruiting

Caprini Score in Venous Surgery: a Prospective Cohort Study (CAPSIVS)

Varicose Veins | Venous Thromboembolism

Russian Federation
Centre Hospitalier Universitaire de Nīmes
Medtronic

Recruiting

Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1) (AVATAR)

Transcatheter Aortic Valve Replacement

France
Cedars-Sinai Medical Center

Recruiting

Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation (RESOLVE)

Prosthetic Valve Thrombosis

United States
GWT-TUD GmbH

Recruiting

Register for New Oral Anticoagulants (NOAC)

Anticoagulation Treatment

Germany
JDP Therapeutics, Inc.

Completed

Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

Acute Urticaria

Canada, United States
Nippon Medical School
Daiichi Sankyo Co., Ltd.

Active, not recruiting

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study (STABLED)

Ischemic Stroke | Atrial Fibrillation Non-Rheumatic

Japan
The Netherlands Cancer Institute
Bristol-Myers Squibb

Terminated

Early Response Evaluation in NSCLC Patients Treated With Immunotherapy

NSCLC, Stage IV

Netherlands
University of Texas at Austin
Lone Star Stroke Research Consortium; Texas Department of State Health Services

Active, not recruiting

Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation (START)

Stroke

United States
Insel Gruppe AG, University Hospital Bern

Completed

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial (ELAN)

Ischaemic Stroke

Belgium, Ireland, Israel, Germany, India, United Kingdom, Austria, Switzerland, Finland, Norway, Italy, Portugal, Slovakia, Japan, Greece
Saint Luke's Health System
Bristol-Myers Squibb; AliveCor

Completed

Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm (BOAT OAR)

Non-valvular Atrial Fibrillation

United States
University of Turku

Completed

Atrial Fibrillation as a Cause of Stroke and Intracranial Hemorrhage Study (The FibStroke Study) (FibStroke)

Stroke | Atrial Fibrillation | Transient Ischemic Attacks | Intracranial Hemorrhage

Finland
William Beaumont Hospitals
Johns Hopkins University; University of Pennsylvania; London Health Sciences...

Withdrawn

Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation

Atrial Fibrillation

United States
Arianna Anticoagulazione Foundation

Terminated

Apixaban for Extended Anticoagulation (APIDULCIS) (APIDULCIS)

Venous Thromboembolism | Anticoagulants

Italy
Damascus University
Unipharma, HamaPharma, Almujtahed hospital

Completed

Rivaroxaban vs. Warfarin in CVT Treatment (RWCVT)

Cerebral Vein Thrombosis

Syrian Arab Republic
Ying Li
Afﬁliated Hospital of North Sichuan Medical College

Enrolling by invitation

Effect of Vitamin K2 in the Treatment of Nocturnal Leg Cramps in Older Population

Nocturnal Leg Cramps

China
The George Institute for Global Health, China
Takeda; Medical Research Council; Department for International Development, United... and other collaborators

Completed

The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT3)

Cardiovascular Diseases | Stroke | Central Nervous System Diseases | Hypertension | Diabetes | Hemorrhage | Intracranial Hemorrhages | Cerebral Hemorrhage | Anticoagulant-induced Bleeding | Cerebral Vascular Disorder | Brain Disorder

China
Qilu Hospital of Shandong University
Liaocheng People's Hospital; Taian City Central Hospital

Completed

Safety of Anticoagulant Therapy After Endoscopic Treatment

Cirrhosis | Esophageal and Gastric Varices | Portal Vein Thrombosis | Anticoagulant-induced Bleeding

China
Bristol-Myers Squibb

Completed

A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan

COVID-19

Japan
University Hospital Tuebingen
Bristol-Myers Squibb; Medtronic; ZKS and IKEaB Tübingen

Completed

Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS)

Embolic Stroke of Undetermined Source

Germany
UMC Utrecht
Dutch Heart Foundation; ZonMw: The Netherlands Organisation for Health Research...

Completed

Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation (APACHE-AF)

Atrial Fibrillation | Cerebral Hemorrhage

Netherlands
Center of Personalized Medicine, Pirogova
University of Rochester; I.M. Sechenov First Moscow State Medical University; Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health and other collaborators

Completed

Personalized Evidence-based Medicine in Patients With Atrial Fibrillation

Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke

Russian Federation
Pirogov Russian National Research Medical University

Completed

Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis (RIDILOTT-DVT)

Deep Vein Thrombosis | Postthrombotic Syndrome

Russian Federation
Benha University

Completed

Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic

Covid19

Egypt
Karolinska Institutet
Stockholm South General Hospital

Completed

Fast Reversal of Warfarin and Early Surgery in Patients With Trochanteric Hip Fracture A Case-control Study

Trochanteric Hip Fractures | Warfarin Medication | Early Surgery

Sweden
Indiana University
Bristol-Myers Squibb; Pfizer; Janssen Pharmaceuticals

Completed

Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism (MATHVTE)

Venous Thromboembolism

United States
Hamad Medical Corporation

Unknown

Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial

Anticoagulation in COVID-19 ARDS

Qatar
Perosphere Pharmaceuticals Inc, a wholly owned...

Completed

Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban (PER977-P1)

Anticoagulant Reversal | Reversal of Edoxaban Induced Anticoagulation

United States
St. Antonius Hospital

Completed

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (POPular-TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Disease

Netherlands, Belgium, Czechia, Luxembourg
R&D Cardiologie
St. Antonius Hospital

Unknown

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. (WOEST 2)

Myocardial Infarction | Stroke | Bleeding | Acute Coronary Syndromes | Coronary Artery Diseases | Atrial Fibrillations | Heart Valve Prostheses

Belgium, Netherlands
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery (TEXT-TKR)

VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery

Belgium, Italy, Malaysia, Latvia, Spain, Turkey, Bulgaria, United States, Lithuania, Russian Federation, Ukraine, Japan, Argentina, Brazil, Canada, Poland
AHEPA University Hospital

Completed

Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF) (MISOAC-AF)

Patient Compliance | Patient Adherence

Greece
University Hospital, Angers

Completed

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation (VICTORIA)

Venous Thrombosis | Pulmonary Embolism | Permanent Atrial Fibrillation | Anticoagulation Treatment at Least > or = to 12-month

France
Second Affiliated Hospital of Nanchang University
Ministry of Science and Technology of the People´s Republic of China

Completed

Monitor System for the Safety of Dabigatran Treatment (MISSION-AF)

Atrial Fibrillation

China
Rennes University Hospital
SFMV (French Society of Vascular Medicine)

Unknown

What Treatment for Patients With Phlebitis or Pulmonary Embolism ? (AntiCoagChoice)

Venous Thrombosis or Pulmonary Embolism

France
Fundació Institut de Recerca de l'Hospital de la...

Completed

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment (ORION)

Self Management of Oral Anticoagulation With VKA Therapy

Spain
Abbott Medical Devices

Withdrawn

ACTION - Anticoagulation Treatment Influence on Post-operative Patients

Heart Valve Disease
Bayer
Janssen Research & Development, LLC

Completed

Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden

Atrial Fibrillation

Sweden
Bristol-Myers Squibb
Pfizer

Completed

Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy (RE-FIT)

Anticoagulation

Italy
Brigham and Women's Hospital
Sanofi

Completed

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism

Deep Vein Thrombosis | Pulmonary Embolism

United States

Search clinical trials for: anticoagulation treatment

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations